Premier Biomedical, Inc.

BIEI

US74048K2033

Specialty Chemicals

Market Closed - OTC Markets Other stock markets 20:58:36 17/05/2024 BST			5-day change	1st Jan Change
0.0016 ^USD	-5.88%		0.00%	+77.78%

03-07	Premier Graphene, Inc. Appoints Gustavo Carreño as Chief Technology Officer	CI
2022	Nova-Graphene Ballistics, Inc. Announces Agreements to Manufacture its Revolutionary 3D-Printed Ballistic Armor Using its Proprietary Graphene Production Methodology	CI

Premier Biomedical, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019

August 14, 2019 at 09:38 pm

Premier Biomedical, Inc. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced sales was USD 3,774 compared to USD 12,089 a year ago. Operating loss was USD 72,944 compared to USD 79,598 a year ago. Net loss was USD 227,048 compared to USD 100,006 a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.03 a year ago. For the half year, sales was USD 9,510 compared to USD 22,484 a year ago. Operating loss was USD 155,134 compared to USD 149,369 a year ago. Net loss was USD 158,537 compared to net income of USD 466,318 a year ago. Basic loss per share from continuing operations was USD 0.02 compared to basic earnings per share from continuing operations of USD 0.16 a year ago.

Latest news about Premier Biomedical, Inc.

Premier Graphene, Inc. Appoints Gustavo Carreño as Chief Technology Officer	03-07	CI
Nova-Graphene Ballistics, Inc. Announces Agreements to Manufacture its Revolutionary 3D-Printed Ballistic Armor Using its Proprietary Graphene Production Methodology	20/12/22	CI
Itaú Unibanco S A : Brazilian billionaire Lemann leads initiative to build COVID-19 vaccine factory	07/08/20	RE
William A. Hartman Resigns as Chief Executive Officer of Premier Biomedical, Inc	01/06/20	CI
Heidi H. Carl Resigns as Chief Financial Officer of Premier Biomedical, Inc	01/06/20	CI
Premier Biomedical, Inc. Announces Executive Changes	01/06/20	CI
Premier Biomedical, Inc. Appoints David Caplan to the Board of Directors	01/06/20	CI
Premier Biomedical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	15/05/20	CI
Premier Biomedical, Inc. Announces Resignation of Mitchell Felder as Chairman and Member of Board of Directors	07/05/20	CI
Premier Biomedical, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	14/11/19	CI
Premier Biomedical, Inc. announced that it has received $0.025 million in funding from Green Coast Capital International S.A.	02/10/19	CI
Premier Biomedical, Inc. announced that it expects to receive $5 million in funding from Green Coast Capital International S.A.	25/09/19	CI
Premier Biomedical, Inc. announced that it has received $0.043 million in funding from PowerUp Lending Group, Ltd.	15/08/19	CI
Premier Biomedical, Inc. announced that it expects to receive $0.043 million in funding from PowerUp Lending Group, Ltd.	14/08/19	CI
Premier Biomedical, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	14/08/19	CI
Premier Biomedical, Inc. announced that it has received $0.038 million in funding from PowerUp Lending Group, Ltd.	06/08/19	CI
Premier Biomedical, Inc. Announces Joint Venture with New Earth Development Corporation, Rushnet, Inc., and XYZ Hemp, Inc	06/08/19	CI
Premier Biomedical, Inc. announced that it expects to receive $0.038 million in funding from PowerUp Lending Group, Ltd.	01/08/19	CI
Premier Biomedical, Inc. Announces Signing of an Agreement Forming a Joint Venture with New Earth Development Corporation, RushNet, Inc., and XYZ Hemp, Inc	29/07/19	CI
Premier Biomedical, Inc. announced that it has received $0.038 million in funding from PowerUp Lending Group, Ltd.	11/06/19	CI
Premier Biomedical, Inc. announced that it expects to receive $0.038 million in funding from PowerUp Lending Group, Ltd.	06/06/19	CI
Premier Biomedical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019	15/05/19	CI
Premier Biomedical, Inc. announced that it has received $0.038 million in funding from PowerUp Lending Group, Ltd.	22/04/19	CI
Premier Biomedical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2018	15/04/19	CI
Premier Biomedical, Inc. announced that it has received $0.068 million in funding from PowerUp Lending Group, Ltd.	27/03/19	CI

Chart Premier Biomedical, Inc.

Duration

Period

More charts

Company Profile

Premier Graphene, Inc. is a global advanced materials firm with a focus on research, production and marketing of eco-friendly graphene. The Companyâs graphene and novel additive formulations are integrated into the production process of other products. The Company is engaged in supplying large-scale industrial quantities. Its proprietary graphene blends and formulations target specific product enhancements sought by manufacturers.

Sector

Specialty Chemicals

More about the company

Sector Other Specialty Chemicals

	1st Jan change	Capi.
PREMIER BIOMEDICAL, INC.	+77.78%	1.87M
ECOLAB INC.	+17.80%	66.43B
SIKA AG	+2.92%	49.89B
GIVAUDAN SA	+19.98%	41.88B
FUJIFILM HOLDINGS CORPORATION	+20.88%	26.48B
EMS-CHEMIE HOLDING AG	+12.04%	19.68B
CELANESE CORPORATION	+1.27%	17B
POSCO FUTURE M CO., LTD.	-22.98%	16.12B
SYMRISE AG	+2.77%	15.28B
ALBEMARLE CORPORATION	-9.25%	15.18B

Other Specialty Chemicals